Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
The Oncologist|April 14, 2018
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung CancerManmeet S Ahluwalia, Kevin Becker, Benjamin P LevyClinical Advances in Hematology & Oncology : H&O|May 28, 2024
Antibody-drug conjugates in advanced lung cancer: Is this a new frontier?Joshua E Reuss, Samuel Rosner, Benjamin P LevyOncology (Williston Park, N.Y.)|July 20, 2016
Attacking a Moving Target: Understanding Resistance and Managing Progression in EGFR-Positive Lung Cancer Patients Treated With Tyrosine Kinase InhibitorsBenjamin P Levy, Parth Rao, Daniel J Becker, et al.Oncology (Williston Park, N.Y.)|December 9, 2010
Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?Benjamin P Levy, Alexander Drilon, Liana Makarian, et al.Investigational New Drugs|September 23, 2017
Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trialAnish B Parikh, Peter Kozuch, Nicholas Rohs, et al.Clinical Lung Cancer|December 29, 2016
Survival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor TherapyDaniel J Becker, Juan P Wisnivesky, Michael L Grossbard, et al.Journal of Oncology Practice|May 12, 2017
Exploration of the ASCO and ESMO Value Frameworks for Antineoplastic DrugsDaniel J Becker, Daniel Lin, Steve Lee, et al.Cancer Treatment and Research Communications|May 19, 2019
A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancerAnish B Parikh, Kristen A Marrone, Daniel J Becker, et al.Journal of Oncology Practice|August 15, 2013
Impact of oncology drug shortages on patient therapy: unplanned treatment changesDaniel J Becker, Sumit Talwar, Benjamin P Levy, et al.Journal for Immunotherapy of Cancer|January 19, 2023
Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapyLavanya Sivapalan, Joseph C Murray, Jenna VanLiere Canzoniero, et al.Pageof 3